TEVA: Teva partners with Klinge Biospharma, Formycon for Eylea biosimilar candidate in Europe, Israel
Eylea is used to treat neovascular age-related macular degeneration and other severe retinal diseases.
Read full article »
Teva is an Israel-based pharmaceutical company that develops and commercializes generic drugs for the treatment of cancer and respiratory diseases around the world.
Read more